Uniwersytet Mikolaja Kopernika w Toruniu Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2003
NCT00204191
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

tacrolimus (prograf) (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1